Nox Mobility raises €2 million to enhance night train services across Europe, aiming for sustainable travel solutions.
Author: Elyse Christian
Epoch Biodesign reveals a new biorecycling facility in London, following a successful €10.3 million funding round to advance sustainable nylon production.
Lululemon Athletica has officially appointed former Nike executive Heidi O’Neill as its chief executive officer following a rigorous international corporate search.
Nox Mobility raises €2 million to enhance European night train services for business travelers, focusing on privacy and profitability.
ATMOS has raised €25.7 million to launch its ambitious plan for a space cargo highway, revolutionizing space logistics.
Discover how AI is transforming travel experiences in our latest podcast episode.
STORM Therapeutics introduces groundbreaking RNA modification techniques to advance cancer treatment options.
ONWARD Medical is innovating neurotechnology to restore movement for spinal cord injury patients.
STORM Therapeutics raises $56 million for Phase 2 trials of STC-15, the first METTL3 inhibitor targeting rare sarcoma cancers.
BioLamina, a Stockholm-based BioTech firm, has secured a €20 million financing to advance its matrix biology and cell culture technologies.